GAVISCON

Manufacturer: Haleon US Holdings LLC
Effective date: 2026-02-13
Label type: HUMAN OTC DRUG LABEL
Version: 23
Source: full-release
Hydrated at: 2026-06-01 01:44:07

Label at a glance#

ProductGAVISCON

Active ingredientALUMINUM HYDROXIDE, MAGNESIUM CARBONATE

Label structure17 sections

Indications and uses

relieves heartburn acid indigestion sour stomach upset stomach associated with these symptoms

Dosage and administration

shake well take 1-2 tablespoonfuls four times a day or as directed by a doctor take after meals and at bedtime dispense product only by spoon or other measuring device

Storage and handling

each tablespoon (15 mL) contains: magnesium 115 mg, sodium 52 mg store at up to 25°C (77°F). Avoid freezing. keep tightly closed

Contacts and useful links#

PhoneLabel contact1-800-452-0051

Websitewww.productpats.com

www.productpats.com

Label contents#

Full prescribing information#

Active ingredients (in each 15 mL tablespoonful) Regular Strength

OTC - ACTIVE INGREDIENT SECTION

Aluminum hydroxide 95 mg

Magnesium carbonate 358 mg

Active ingredients (in each 5 mL / teaspoonful) Extra Strength

OTC - ACTIVE INGREDIENT SECTION

Aluminum hydroxide 254 mg

Magnesium carbonate 237.5 mg

Purposes

OTC - PURPOSE SECTION

Antacid

Uses

INDICATIONS & USAGE SECTION

relieves

heartburn
acid indigestion
sour stomach
upset stomach associated with these symptoms

Warnings

WARNINGS SECTION

Ask a doctor or pharmacist before use if you

OTC - ASK DOCTOR/PHARMACIST SECTION

have kidney disease
are on a sodium-restricted diet or a magnesium-restricted diet
are taking a prescription drug. Antacids may interact with certain prescription drugs.

When using this product (Regular Strength)

OTC - WHEN USING SECTION

do not take more than 8 tablespoonfuls in 24 hours
do not use the maximum dosage for more than 2 weeks except under the advice and supervision of a doctor
laxative effect may occur

When using this product (Extra Strength)

OTC - WHEN USING SECTION

do not take more than 16 teaspoonfuls in 24 hours
do not use the maximum dosage for more than 2 weeks, except under the advice and supervision of a doctor
laxative effect may occur

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions (Regular Strength)

DOSAGE & ADMINISTRATION SECTION

shake well
take 1-2 tablespoonfuls four times a day or as directed by a doctor
take after meals and at bedtime
dispense product only by spoon or other measuring device

Directions (Extra Strength)

DOSAGE & ADMINISTRATION SECTION

shake well
take 2-4 teaspoonfuls four times a day or as directed by a doctor
take after meals and at bedtime
dispense product only by spoon or other measuring device

Other information (Regular Strength)

STORAGE AND HANDLING SECTION

each tablespoon (15 mL) contains:magnesium 115 mg, sodium 52 mg
store at up to 25°C (77°F). Avoid freezing.
keep tightly closed

Other information (Extra Strength)

STORAGE AND HANDLING SECTION

each teaspoon (5 mL) contains:magnesium 75 mg, sodium 11 mg
store at up to 25°C (77°F). Avoid freezing.
keep tightly closed

Inactive ingredients (Regular Strength)

INACTIVE INGREDIENT SECTION

benzyl alcohol, D&C yellow #10, edetate disodium, FD&C blue #1, flavor, glycerin, saccharin sodium, sodium alginate, sorbitol solution, water, xanthan gum

Inactive ingredients (Extra Strength Cool Mint)

INACTIVE INGREDIENT SECTION

benzyl alcohol, edetate disodium, glycerin, natural and artificial flavors, purified water, simethicone emulsion, sodium alginate, sodium saccharin, sorbitol solution, xanthan gum

Inactive ingredients (Extra Strength Cherry)

INACTIVE INGREDIENT SECTION

benzyl alcohol, edetate disodium, glycerin, natural and artificial flavors, purified water, simethicone emulsion, sodium alginate, sodium saccharin, sorbitol solution, xanthan gum

Questions or comments?

OTC - QUESTIONS SECTION

1-800-452-0051

Additional Information

SPL UNCLASSIFIED SECTION

Do not use if printed inner safety seal under cap is broken or missing.

Trademarks are owned by or licensed to the Haleon group of companies.

Pat. Info www.productpats.com

Distributed by:

Haleon

Warren, NJ 07059

Made in Mexico

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0135-0094-41

Gaviscon

LIQUID ANTACID

REGULAR STRENGTH

Fast-Acting Heartburn Relief
Helps Keep Acid Down for Hours

COOL MINT

FLAVOR

12 FL OZ (355 mL)

FRONT: 00067473

BACK: 00067474

00067473 Gaviscon Regular Strength 12 fl oz

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HALEON

Gaviscon

LIQUID ANTACID

EXTRA STRENGTH

Fast-Acting Heartburn Relief
Helps Keep Acid Down for Hours

COOL MINT
FLAVOR

12 FL OZ (355 mL)

FRONT: 00213316

BACK: 00213317

Gaviscon Extra Strength Cool Mint 12 fl oz label.jpg

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HALEON

Gaviscon

LIQUID ANTACID

EXTRA STRENGTH

Fast-Acting Heartburn Relief
Helps Keep Acid Down for Hours

CHERRY
FLAVOR

12 FL OZ (355 mL)

FRONT: 00213320

BACK: 00213322

Gaviscon Extra Strength 12 fl oz label.jpg

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
245001	aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG in 5 mL Oral Suspension	PSN	23
252203	aluminum hydroxide 95 MG / magnesium carbonate 358 MG in 15 mL Oral Suspension	PSN	23
404472	Gaviscon Extra Strength 254 MG / 237.5 MG in 5 mL Oral Suspension	PSN	23
1251365	Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension	PSN	23
404472	aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon]	SBD	23
1251365	aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]	SBD	23
245001	aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension	SCD	23
252203	aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension	SCD	23
245001	aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG per 5 ML Oral Suspension	SY	23
252203	aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG per 5 ML Oral Suspension	SY	23
252203	aluminum hydroxide 32 MG / magnesium carbonate 119 MG per 5 ML Oral Suspension	SY	23
252203	aluminum hydroxide 95 MG / magnesium carbonate 358 MG per 15 ML Oral Suspension	SY	23
1251365	Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension	SY	23
1251365	Gaviscon (aluminum hydroxide 95 MG / magnesium carbonate 358 MG) per 15 ML Oral Suspension	SY	23
404472	Gaviscon Extra Strength Liquid (aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG) per 5 ML Oral Suspension	SY	23

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6084a4f4-5437-c9a5-caec-5361ee075a59	Product name	1	20140508
90c5639a-61b0-88d6-ddcf-21888e94869a	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
9869efd7-d6dd-0665-5b67-53adbe6ef15e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0135-0094-41	GAVISCON	355 mL in 1 BOTTLE	LIQUID	355	23
0135-0094-42	GAVISCON	177 mL in 1 BOTTLE	LIQUID	177	23
0135-0095-41	GAVISCON	355 mL in 1 BOTTLE	LIQUID	355	23
0135-0574-01	GAVISCON	355 mL in 1 BOTTLE	LIQUID	355	23

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0135-0094-41	ML - Milliliter	0135-0094	f54ea608-8f95-4e6d-b1f4-e9383834924b	1	2012-07-24
0135-0094-42	ML - Milliliter	0135-0094	0fcc772c-1b89-490e-b83a-667675a94c8a	1	2018-09-05
0135-0095-41	ML - Milliliter	0135-0095	8a89799b-6ea4-41da-b54a-56f8d61cdd08	1	2012-07-24
0135-0574-01	ML - Milliliter	0135-0574	acc128fb-e721-46a0-a8c7-3a2e23489205	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALUMINUM HYDROXIDE	ACTIVE INGREDIENT	5QB0T2IUN0	7
MAGNESIUM CARBONATE	ACTIVE INGREDIENT	0E53J927NA	7
ALUMINUM HYDROXIDE	ACTIVE MOIETY	5QB0T2IUN0	7
CARBONATE ION	ACTIVE MOIETY	7UJQ5OPE7D	7
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	7
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	7
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	7
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	7
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	7
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	7
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	7
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	7
SODIUM ALGINATE	INACTIVE INGREDIENT	C269C4G2ZQ	7
SORBITOL	INACTIVE INGREDIENT	506T60A25R	7
WATER	INACTIVE INGREDIENT	059QF0KO0R	7
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	7

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

GAVISCON
aluminum hydroxide and magnesium carbonate
BENZYL ALCOHOL
EDETATE DISODIUM
GLYCERIN
WATER
SODIUM ALGINATE
SACCHARIN SODIUM
SORBITOL
XANTHAN GUM
ALUMINUM HYDROXIDE
MAGNESIUM CARBONATE
CARBONATE ION
DIMETHICONE, UNSPECIFIED

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0135-0094	0135-0094-41, 0135-0094-42
0135-0095	0135-0095-41
0135-0574	0135-0574-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 32 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BENZYL ALCOHOL	LKG8494WBH	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
GLYCERIN	PDC6A3C0OX	IACT
WATER	059QF0KO0R	IACT
SODIUM ALGINATE	C269C4G2ZQ	IACT
SACCHARIN SODIUM	SB8ZUX40TY	IACT
SORBITOL	506T60A25R	IACT
XANTHAN GUM	TTV12P4NEE	IACT
ALUMINUM HYDROXIDE	5QB0T2IUN0	ACTIB
MAGNESIUM CARBONATE	0E53J927NA	ACTIB
BENZYL ALCOHOL	LKG8494WBH	IACT
DIMETHICONE, UNSPECIFIED	92RU3N3Y1O	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
GLYCERIN	PDC6A3C0OX	IACT
SACCHARIN SODIUM	SB8ZUX40TY	IACT
SODIUM ALGINATE	C269C4G2ZQ	IACT
SORBITOL	506T60A25R	IACT
XANTHAN GUM	TTV12P4NEE	IACT
WATER	059QF0KO0R	IACT
ALUMINUM HYDROXIDE	5QB0T2IUN0	ACTIB
MAGNESIUM CARBONATE	0E53J927NA	ACTIB
BENZYL ALCOHOL	LKG8494WBH	IACT
DIMETHICONE, UNSPECIFIED	92RU3N3Y1O	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
GLYCERIN	PDC6A3C0OX	IACT
SACCHARIN SODIUM	SB8ZUX40TY	IACT
SODIUM ALGINATE	C269C4G2ZQ	IACT
SORBITOL	506T60A25R	IACT
WATER	059QF0KO0R	IACT
XANTHAN GUM	TTV12P4NEE	IACT
ALUMINUM HYDROXIDE	5QB0T2IUN0	ACTIB
MAGNESIUM CARBONATE	0E53J927NA	ACTIB

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
Version	Effective date	Source	Hydrated
22	2026-01-23	monthly-update	2026-06-03 17:53:07
21	2025-12-27	monthly-update	2026-06-03 17:46:41

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 11 · 658 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, EXTENDED RELEASE / ORAL		168 mg	Exact identifier — unii+route 238 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET, FILM COATED / ORAL	120 mg		Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SUSPENSION / ORAL		2553 mg	Exact identifier — unii+route 238 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	TABLET / ORAL		56 mg	Exact identifier — unii+route 133 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	DROPS / ORAL	NA		Exact identifier — unii+route 238 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	SUSPENSION, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii+route 147 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	SYRUP / ORAL	3 mg/1ml		Exact identifier — unii+route 56 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / ORAL		100 mg	Exact identifier — unii+route 49 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	SUSPENSION / ORAL		49 mg	Exact identifier — unii+route 56 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	SUSPENSION / ORAL		49 mg	Exact identifier — unii+route 56 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SOLUTION / ORAL		280 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SUSPENSION, EXTENDED RELEASE / ORAL		70 mg	Exact identifier — unii+route 238 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET, COATED / ORAL	2.5 mg		Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE / ORAL		254 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		336 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION / ORAL		200 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	CAPSULE / ORAL		160 mg	Exact identifier — unii+route 56 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	SYRUP / ORAL		4 mg	Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SOLUTION / ORAL	1.8 mg/120ml		Exact identifier — unii+route 238 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	LIQUID / ORAL	0.5 mg/1ml		Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	SUSPENSION / ORAL		360 mg	Exact identifier — unii+route 133 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii+route 238 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / ORAL		360 mg	Exact identifier — unii+route 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / ORAL		750 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE / ORAL		1190 mg	Exact identifier — unii+route 238 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	CAPSULE / ORAL	20 mg		Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, EXTENDED RELEASE / ORAL		168 mg	Exact identifier — unii+route 238 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / ORAL		100 mg	Exact identifier — unii+route 49 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	POWDER, FOR SOLUTION / ORAL	10 mg/5ml		Exact identifier — unii+route 133 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET / ORAL	80 mg		Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii+route 238 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET, COATED / ORAL	2.5 mg		Exact identifier — unii+route 147 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET / ORAL	1.06 mg		Exact identifier — unii+route 49 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	SOLUTION / ORAL		84 mg	Exact identifier — unii+route 133 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CAPSULE, EXTENDED RELEASE / ORAL	1.23 mg		Exact identifier — unii+route 49 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	LOZENGE / ORAL		1274 mg	Exact identifier — unii+route 56 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, EXTENDED RELEASE / ORAL		168 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, COATED / ORAL		3 mg	Exact identifier — unii+route 238 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	TABLET / ORAL	80 mg		Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE / ORAL	5000 mg		Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, DELAYED RELEASE / ORAL	3.2 mg		Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	LOZENGE / ORAL		120 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	SYRUP / ORAL	3 mg/1ml		Exact identifier — unii+route 56 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	GUM, CHEWING / ORAL		2 mg	Exact identifier — unii+route 147 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	SOLUTION / ORAL		8 mg	Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, COATED / ORAL		176 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, COATED / ORAL		3 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE / ORAL		1190 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SODIUM ALGINATE	SODIUM ALGINATE	C269C4G2ZQ	TABLET / ORAL		480 mg	Exact identifier — unii+route 56 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET / ORAL	1.06 mg		Exact identifier — unii+route 49 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	LIQUID / INTRAVENOUS	1.04 %w/v		Exact identifier — unii+dosage form 49 equally ranked IID candidates
D&C YELLOW NO. 10	D&C YELLOW NO. 10	35SW5USQ3G	POWDER, FOR SUSPENSION / ORAL		76 mg	Exact identifier — unii+route 147 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE / ORAL		254 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FOR SUSPENSION / ORAL		220 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii+route 238 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii+route 238 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET, DELAYED RELEASE / ORAL	2.31 mg		Exact identifier — unii+route 49 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GAVISCON	ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE	Haleon US Holdings LLC	2d74e5bc-1f10-4fb6-9258-cd906e360013	2026-02-13	Warnings	Exact identifier ndc (package): 0135-0094-41 ndc (package): 0135-0574-01 ndc (package): 0135-0094-42 ndc (package): 0135-0095-41 ndc (product): 0135-0095 ndc (product): 0135-0574 ndc (product): 0135-0094 ndc11 (package): 00135009442 ndc11 (package): 00135009541 ndc11 (package): 00135009441 ndc11 (package): 00135057401 spl id: 4aba2043-4dde-0c18-e063-6294a90a5fcf spl set id: 2d74e5bc-1f10-4fb6-9258-cd906e360013

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.